Low-cost, nanometer-sized drug holds promise for treatment of chronic diabetes and burn wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from Israel, the U.S. and Japan.